bis(4-nitrophenyl)phosphate has been researched along with Alzheimer Disease in 2 studies
bis(4-nitrophenyl)phosphate: RN given refers to parent cpd
Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Makhaeva, GF | 2 |
| Lushchekina, SV | 2 |
| Boltneva, NP | 2 |
| Serebryakova, OG | 2 |
| Rudakova, EV | 2 |
| Ustyugov, AA | 1 |
| Bachurin, SO | 1 |
| Shchepochkin, AV | 1 |
| Chupakhin, ON | 1 |
| Charushin, VN | 1 |
| Richardson, RJ | 2 |
| Kulikova, LN | 1 |
| Beloglazkin, AA | 1 |
| Borisov, RS | 1 |
2 other studies available for bis(4-nitrophenyl)phosphate and Alzheimer Disease
| Article | Year |
|---|---|
9-Substituted acridine derivatives as acetylcholinesterase and butyrylcholinesterase inhibitors possessing antioxidant activity for Alzheimer's disease treatment.
Topics: Acetylcholinesterase; Acridines; Alzheimer Disease; Animals; Antioxidants; Butyrylcholinesterase; Ch | 2017 |
Synthesis, molecular docking, and biological activity of 2-vinyl chromones: Toward selective butyrylcholinesterase inhibitors for potential Alzheimer's disease therapeutics.
Topics: Acetylcholinesterase; Alzheimer Disease; Binding Sites; Butyrylcholinesterase; Cholinesterase Inhibi | 2018 |